Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1028486-01-2 | MDL No. : | MFCD16621243 |
Formula : | C27H20ClFN4O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZLHFILGSQDJULK-UHFFFAOYSA-N |
M.W : | 518.92 | Pubchem ID : | 24771867 |
Synonyms : |
MLN 8237
|
Chemical Name : | 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid |
Num. heavy atoms : | 37 |
Num. arom. heavy atoms : | 24 |
Fraction Csp3 : | 0.11 |
Num. rotatable bonds : | 6 |
Num. H-bond acceptors : | 8.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 141.24 |
TPSA : | 105.93 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.9 cm/s |
Log Po/w (iLOGP) : | 3.76 |
Log Po/w (XLOGP3) : | 5.02 |
Log Po/w (WLOGP) : | 5.63 |
Log Po/w (MLOGP) : | 2.09 |
Log Po/w (SILICOS-IT) : | 5.89 |
Consensus Log Po/w : | 4.48 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -6.3 |
Solubility : | 0.000258 mg/ml ; 0.000000497 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -6.98 |
Solubility : | 0.0000537 mg/ml ; 0.000000104 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -10.16 |
Solubility : | 0.0000000356 mg/ml ; 0.0000000001 mol/l |
Class : | Insoluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 4.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | Stage #1: With potassium carbonate In methanol at 50 - 55℃; for 24 h; Stage #2: With hydrogenchloride In methanol; water at 20 - 55℃; for 2 h; |
4-{f9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-rf1[2lbenzazepin-2- ynamino)-2-methoxybenzoic acid (Formula II)[0156] Into a reactor was added 6 (3.81kg, 15.5mol), potassium carbonate (4.3kg, 31.1mol), 9 (5.27kg, 14.1mol) and methanol (63L). The suspension was warmed to 50 to 55 °C and stirred for a minimum of 24h until >96.0percent conversion was obtained by HPLC analysis. Methanol (10L) and water (37L) were added while maintaining the temperature between 50 and 55 °C. The pH of the mixture was adjusted to 3.0 to 4.0 using 7percent w/ w HC1 (prepared from 7.0kg of concentrated HQ and 24L of water) while maintaining the temperature between 50 and 55 °C. The suspension was cooled to 20 to 25 °C over a minimum of lh and stirred for at least 60min. The resulting suspension was filtered and washed with water (2 x 26.3L) at 50 to 55 °C and methanol (2 x 10L) at 20 to 25 °C. The wet cake was dried at 45 to 50 °C under vacuum to provide 5.85kg (80percent yield) of Formula (II). 3/4 NMR (300 MHz, DMSO-d6) δ 12.07 (s, IH), 10.22(s, IH), 8.72 (s, IH), 8.29 (d, J=8.8 Hz, IH), 7.95 (s, IH), 7.80 (dd, J=2.4, 8.9 Hz, IH), 7.70 (d, J=8.8 Hz, IH), 7.39 (m, 3H), 7.21 (s, IH), 6.89 (s, 2H), 3.82 (s, 6H); MS (ESI) m/z MS (ESI) m/z 517.2 (M - H+, 45percent). |